Form 8-K - Current report:
SEC Accession No. 0001641172-25-009462
Filing Date
2025-05-09
Accepted
2025-05-09 16:30:11
Documents
15
Period of Report
2025-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 36406
2 EX-99.1 ex99-1.htm EX-99.1 58998
  Complete submission text file 0001641172-25-009462.txt   323671

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE celu-20250509.xsd EX-101.SCH 3891
4 XBRL DEFINITION FILE celu-20250509_def.xml EX-101.DEF 26798
5 XBRL LABEL FILE celu-20250509_lab.xml EX-101.LAB 37062
6 XBRL PRESENTATION FILE celu-20250509_pre.xml EX-101.PRE 25422
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6048
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

EIN.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 25930904
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)